Phase III safety studies will not be completed until 2023 …. not only that … BUT In going through the Reg 174 document, it becomes very clear that there are many issues and recommendations that are being hidden from the general public
… Possibly the most fascinating admission in the entire document is the absence of any compatibility studies when somebody is given the vaccine while on any other medication or medical treatment. The guidance clearly states “this medicinal product should not be mixed with other medical products.” This completely jaw dropping sentence will lead many to assume that if you are on any medication at all, then you shouldn’t be given the vaccine. Whether this refers to the mixing of other medical properties directly together with the vaccine, or simultaneous dosing of any other medical product is unclear from the official guidance.